Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs State Street Corporation Common Stock (STT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs State Street Corporation Common Stock — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while State Street Corporation Common Stock trades at $175.23 (market cap $47.85B). The key difference: State Street Corporation Common Stock is the larger of the two by market cap, and State Street Corporation Common Stock pays the higher dividend (2.11%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and State Street Corporation Common Stock for 0 Days on average.
| RPRX | STT | |
|---|---|---|
Market Cap | $25.27B | $47.85B |
Volume | 3,671,183 | 1,607,448 |
Sector | Health | Financials |
52-Week High | $63.96 | $194.26 |
52-Week Low | $35.44 | $111.00 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $32.50B | $74.39B |
Dividend Yield | 1.66% | 2.11% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About State Street Corporation Common Stock
State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.
Read more on STT →
